Mizuho initiated coverage on Neon Therapeutics Inc (NASDAQ:NTGN) with a “buy” rating and $21 price target — a 333% premium to last night’s close. The brokerage firm said NTGN’s low share price is a …

More Analyst: This Penny Stock Could Quadruple Videos